פרסומים.doc
Upcoming SlideShare
Loading in...5
×
 

פרסומים.doc

on

  • 326 views

 

Statistics

Views

Total Views
326
Views on SlideShare
326
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

פרסומים.doc פרסומים.doc Document Transcript

  • LIST OF PUBLICATIONS i) DOCTORATE THESIS - ii) BOOKS - iii) EDITOR OF BOOKS - iv) CHAPTERS IN BOOKS 1. Genetic factors in the etiology of bipolar disorder. Segman RH & Lerer B. (2000) in Basic mechanisms and therapeutic implications of bipolar disorder. Soars JC, Gershon S. (Eds). Marcel Dekker New York 2. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia: The potential role of candidate genes. Segman R. and Lerer B. (2000) in Progress in Differentiated Psychopathology. Franzek E, Ruether E, Ungvari GS, Beckmann H Eds. Wuerzburg University Press, Wuerzburg, 3. Genetics of Tardive Dyskinesia. Segman RH. Lerer B. (2002) In Pharmacogenetics of Psychotropic drugs Lerer B. Ed. Cambridge University Press, Cambridge UK . v) PATENTS - vi) ORIGINAL PAPERS IN PEER REVIEWED JOURNALS 1. King RA, Segman RH, Anderson GM. (1994) Serotonin and suicidality: The impact of acute fluoxetine administration. Part I: Serotonin and suicide. Israel Journal of Psychiatry 31:4:271-279.
  • 2. Anderson GM, Segman RH, King RA. (1995) Serotonin and suicidality: The impact of acute fluoxetine administration. Part II: Acute neurobiological effects. Israel Journal of Psychiatry 32;1:44-50. 3. Segman RH, Shapira B, Gorfine M, Lerer B. (1995) Onset and time course of antidepressant action: Psychopharmacological implications of a controlled trial of electroconvulsive therapy. Psychopharmacology. 119; 440-448. (2.804; 30/181; 18:18 B) 4. Kotler Y, Cohen H, Segman R, Gricenco I, Nemanov L, Ebstein RP. (1997) Excess dopamine D4 receptor exon III seven repeat allele in opiate dependent subjects. Molecular Psychiatry. 2(3)251-254. [8.927; 2/82; 71:71 A] 5. Ebstein RP, Segman R, Benjamine J, Osher Y, Nemanov L, Belmaker R (1997) 5-HT2c receptor polymorphism associated with the human personality trait of reward dependence: Interaction with dopamine D4 receptor and dopamine D3 receptor polymorphisms. American Journal of Medical Genetics 74:65-72 [2.479; 42/114; 61:61 B] 6. Segman R, Ebstein RP, Levi U, Gorfine M, Shapira B, Avnon M, Gur E, Lerer B. (1997) 5-HT2C receptor gene polymorphism, schizophrenia and chronic hospitalisation. Psychiatric Genetics 7:2: 75-79. [2.609; 39/114; 12:10] 7. Amar A, Segman RH, Shtrussberg S, Sherman L, Safirman C, Lerer B, Brautbar C. Granulocytopenia in clozapine treated schizophrenia may be associated with HLA-DBQ1*0201. International Journal of Neuropsychopharmacology (1998) 1:41-44. [1.323 49/82; 5:5 C] 8. Schreiber S, Klag E, Gross Y, Segman RH, Pick CG. (1998) Beneficial effect of risperidone on sleep disturbance and psychosis following traumatic brain injury: International Clinical Psychopharmacology 13(6):273-275. [2.076; 50/181; 2:2 C]
  • 9. Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Honig S, Straub M Hanses, Segman R, Lichtermann DC, Knapp M, Trixler M, Maier W, Wildenauer DB. (1998) Support for a locus on chromosome 18p conferring susceptibility to functional psychoses in families with schizophrenia by association and linkage analysis. American Journal of Human Genetics 63:4:1139-52. [10.351; 6/114; 44:44 B] 10. Schwab SG, Hallmayer J, Hanses C, Albus M, Lerer B, Kanyas K, Segman R, Borrmann R, Dreikorn B, Lichtermann D, Rietschel M, Held T, Ertl MA, Maier W, Wildenauer DB. (1998) Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by non parametric linkage analysis American Journal of Medical Genetics 10:81(4):302-7. [2.479; 42/114; 49:48 B] 11. Segman RH, Neeman TS, Heresco-Levy U, Finkel B, Karagacev L, Schlafman M, Durevich A, Yakir A, Lerner A, Shelevoy A, Lerer B. (1999) Genotypic association between the dopamine D3 receptor gene and tardive dyskinesia in chronic schizophrenia. Molecular Psychiatry 4:247-253. [8.927; 2/82;42: 36 A] 12. Wittekindt O, Schwab SG, Burgert E, Knapp M, Albus M, Lerer B, Hallmayer J, Rietschel M, Segman R, Borrmann M, Lichterman D, Crock MA, Maier W, Morris-Rosendahl DJ, Wildeauer DB. (1999) Association between hSKCa3 and schizophrenia not confirmed by Transmission Dysequilibrium Test in 193 offspring/parents trios. Molecular Psychiatry 4:267-270. [8.927; 2/82; 11:11 A] 13.Lerer BPI, Shapira BC, Bloch MC, Hanin BC, Trudart TC, Alexander JRC, Popper MC, Braun DC, Segman RHC, Ritsner MC. (1999) Possible precipitants of psychiatric hospitalization in patients with major depression: results from the Jerusalem Collaborative Depression Project. Depression Anxiety. 9:156-62.
  • 14.Schwab SGPI, Hallmayer JC, Albus MC, Lerer BC, Eckstein MC, Borrmann MC, Segman RC, Hanses CC, Freymann JC, Yakir AC, Kanyas MC, Falkai PC, Rietschel MC, Maier WC, Wildenauer DBC. (2000) A genome-wide screen for schizophrenia susceptibility loci in 71 families with affected siblings: Support for loci on chromosome 10p and 6. Molecular Psychiatry 5:638-649. [8.927; 2/82; 22:21 A] 15.Segman RHPI, Heresco-Levy UC, Finkel BC, Inbar RS, Neeman TS, Schlafman MC, Dorevitch AC, Yakir AC, Lerner AC, Goltser TS, Lerer BcoPI. (2000) Association between the serotonin 2C recptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly to susceptibility. Psychopharmacology 152(4):408-413.[2.804; 30/181; 14:11 B] 16.Segman RHPI, Heresco-Levy UC, Finkel BC, Goltser TSS, Shalem RTS, Schlafman MC, Dorevitch AC, Yakir AC, Greenberg DC, Lerner AC, Lerer BcoPI. Association between the serotonin 2A receptor gene and tardive dykinesia in chronic schizophrenia. Molecular Psychiatry (2001) 6(2):225-9. [8.927; 2/82; 9:6 A] 17. Lerer BPI, Macciardi FC, Segman RHC, Adolfsson RC, Blackwood DC, Blairy SC, Del-Favero JC, Dikeos DC, Kaneva EC., Lilli RC, Massat IC, Milanova VC, Muir WC, Noethen MC, Oruc LC, Petrova TC, Papadimitriou GNC, Rietschel MC, Serretti AC, Souery DC, Van Gestel SC, Van Broeckhoven CC, Mendlewicz JMC. (2001) Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Molecular Psychiatry. 6(5):579-85. [8.927; 2/82; 5:3 A] 18. Segman RHPI, Meltzer AS, Gross-Tsur VC, Kossov AC, Frisch AC, Inbar EC, Darvasi AC, Levy SS, Goltser TS, Weizman AC, Galili-Weisstub EC. (2002) Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder. Molecular Psychiatry 7: 72-74. [8.927; 2/82; 0:0 A]
  • 19.Segman RHPI, Heresco-Levy UC, Yakir AC, Goltser TS, Strous RC, Greenberg DC, Lerer BcoPI. (2002) Interactive Effect of Cytochrome P450 17α- Hydroxylase and Dopamine D3 Receptor Gene Polymorphisms on Abnormal Involuntary Movements in Chronic Schizophrenia Biological Psychiatry 51:261-263. [4.269; 9/82; 2:1 A] 20. Segman RHPI, Lerer BcoPI. (2002) Age and the relationship of dopamine D3 and serotonin 2A receptor genes to abnormal involuntary movements in chronic schizophrenia. Molecular Psychiatry 7: 131-139. [8.927; 2/82; 1:1 A] 21.Segman RHPI, Shapira YS, Modai IC, Hamdan AC, Zislin JC, Heresco-Levy UC, Kanyas KC, Hirschmann SC, Karni OC, Finkel BC, Schlafman MC, Lerner AC, Shapira BC, Macciardi FC, Lerer BcoPI. (2002) Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism: Case-Control Association Studies in Schizophrenia, Major Affective Disorder, and Tardive Dyskinesia and a Family-Based Association Study in Schizophrenia. American Journal of Medical Genetics 114(3):310-4. [2.479; 42/114; 0:0 B] 22.Schwab SGPI, Hallmayer JC, Freimann JC, Lerer BC, Albus MC, Borrmann- Hassenbach MC, Segman RHC, Trixler MC, Rietschel MC, Maier WC, Wildenauer DBPI. (2002) Investigation of linkage and association/linkage disequilibrium of HLA A-,DQA1-, DQB1-, and DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophrenia. American Journal of Medical Genetics. 8;114(3):315-20. [2.479; 42/114; 0:0 B] 23.Massat IPI, Souery DC, Del-Favero JC, Van Gestel SC, Serretti AC, Macciardi FC, Smeraldi EC, Kaneva RC, Adolfsson RC, Nylander POC, Blackwood DC, Muir WC, Papadimitriou GNC, Dikeos DC, Oruc LC, Segman RHC, Ivezic SC, Aschauer HC, Ackenheil MC, Fuchshuber SC, Dam HC, Jakovljevic MC, Peltonen LC, Hilger CC, Hentges FC, Staner LC, Milanova VC, Jazin EC, Lerer BC, Van Broeckhoven CC, Mendlewicz JPI. (2002) Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a
  • European multicenter association study of affective disorders. American Journal of Medical Genetics. 8;114(2):177-85. [2.479; 42/114; 0:0 B] 24. Segman RHPI, Cooper-Kazaz RS, Macciardi FC, Goltser TS, Halfon YC, Dobroborski TT, Shalev AYcoPI. (2002) Association between the Dopamine Transporter Gene and Posttraumatic Stress Disorder. Molecular Psychiatry 7(6):903-7 [8.927; 2/82; 0:0 A] 25. Lerer BPI, Segman RHC Fangerau HC, Daly AKC, Basile VSC, Cavallaro RC, Aschauer HNC, McCreadie RGC, Ohlraun SC, Ferrier NC, Masellis MC, Verga MC, Scharfetter JC, Rietschel MC, Lovlie RC, Heresco Levy UC, Kennedy JLC, Steen VMC, Macciardi FC. (2002) Pharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene ser9gly polymorphism. Neuropsychopharmacology 27(1): 105-119.[4.715; 28/198; 1:1 A] 26. Lerer BPI, Segman RHC., Hamdan AC, Kanyas KC., Karni OC., Kohn YC, Korner MC, Lanktree MC, Kaadan MC, Turetsky NC, Yakir AC, Kerem BC, Macciardi FC: Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Molecular Psychiatry (In Press). 27. Segman RHPI, Goltser TS, Heresco-Levy U C, Finkel BC, Shalem RC, Schlafman MC, Yakir AC, Greenberg DC, Strous RC, Lerner AC, Shelevoy AC, Lerer BcoPI. Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia. The Pharmacogenomic Journal (In Press). vii) CASE REPORTS Schrieber S, Segman R. (1997) Risperidone induced galactorrhea. Psychopharmacology 130:3:300-301. [2.599; 22/153; 0:0]
  • viii) LETTERS Lerer B, Segman R. (1997) Ernst Rudin and German Psychiatric Genetics (Letter) American Journal of Medical Genetics (Neuropsychiatric Genetics) 74: 457-459. [1.955; 35/79; 2:2] ix) REVIEWS, COMMENTARIES, HYPOTHESES, EDITORIALS Editorial Segman RH, Gershon ES. (2002) Genes for human behavior. In Segman RH, Gershon ES. Eds. Psychiatry and Genetics in the new century. Special Issue. Israel Journal of Psychiatry.and Related Sciences 39:4:203-5. Review Galili-Weisstub E, Segman RH. (2003) Attention deficit hyperactivity disorder: Review of molecular genetic studies. Israel Journal of Psychiatry and Related Sciences 40:1: 47-56.